Ageing-related changes in the regulation of microglia and their interaction with neurons

Rommy von Bernhardi1, Jaime Eugenín2

  • 1Universidad San Sebastian, Faculty for Odontology and Rehabilitation Sciences. Lota 2465, Providencia, Santiago, PO. 7510602, Chile.

Neuropharmacology
|December 1, 2024
PubMed

Insights

Aging impairs microglia, the brain's immune cells, leading to neuroinflammation and reduced neuronal support. This age-related dysfunction affects brain health and increases susceptibility to neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Immunology
  • Aging Research

Background:

  • Aging is a major risk factor for neurodegenerative diseases, with inflammation playing a key role.
  • Microglia, the central nervous system's immune cells, have complex roles in maintaining brain homeostasis and responding to stimuli.
  • Age-related inflammation, or inflammaging, impairs microglial function, creating a less supportive environment for neurons.

Purpose of the Study:

  • To examine the impact of aging on microglia function and their regulatory crosstalk with neurons.
  • To focus on the neuron-microglia communication pathways involving fractalkine (CX3CL1), CD200, and Transforming Growth Factor β1 (TGFβ1).

Main Methods:

  • Review of existing literature on microglial function in aging.
  • Analysis of molecular signaling pathways regulating neuron-microglia interactions.

Main Results:

  • Aging leads to dysregulated microglial activation, negatively impacting neuronal survival and function.
  • Impaired microglia exhibit reduced responsiveness to regulatory signals, limiting their protective capabilities.
  • Age-related changes narrow the functional spectrum of microglia, hindering their ability to maintain brain health and respond to disease.

Conclusions:

  • Microglia are central mediators of age-dependent nervous system changes.
  • Dysfunctional microglia contribute to neuroinflammation and neurodegeneration in aging.
  • Targeting neuron-microglia communication pathways may offer therapeutic strategies for age-related neurological decline.